A new class of selective inhibitors of the p110-alpha isoform of PI3K as cancer drugs

被引：0
|
作者：
Denny, William [1 ]
Kendall, Jackie [1 ]
Rewcastle, Gordon [1 ]
Shepherd, Peter [1 ]
Flanagan, Jack [1 ]
Baguley, Bruce [1 ]
Kestell, Phil [1 ]
Giddens, Anna [1 ]
Tsang, Sophia [1 ]
Marshall, Andrew [1 ]
机构：
[1] Univ Auckland, Auckland 1, New Zealand
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY32-1
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Discovery of benzoxazepin PI3K inhibitors and optimization of p110-alpha selectivity
    Ndubaku, Chudi O.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [2] PI3K Isoform-Selective Inhibitors in Cancer
    Duncan, Leslie
    Shay, Chloe
    Teng, Yong
    [J]. SINGLE-CELL SEQUENCING AND METHYLATION: METHODS AND CLINICAL APPLICATIONS, 2020, 1255 : 165 - 173
  • [3] Discovery of novel class of alpha selective PI3K inhibitors
    Garland, Keira
    Hanan, Emily
    Staben, Steven
    Braun, Marie-Gabrielle
    Edgar, Kyle
    Endres, Nick
    Friedman, Lori
    Nguyen, Amanda
    Pang, Jodie
    Purkey, Hans
    Salphati, Laurent
    Schmidt, Stephen
    Song, Kyung
    Ultsch, Mark
    Jaochico, Allan
    Chan, Connie
    Eigenbrot, Charles
    MacLeod, Calum
    Jackson, Philip
    Narukulla, Raman
    Knight, Jamie
    Yeap, Kuen
    Messick, Kristen
    Valle, Nicole
    Heald, Robert
    Nannini, Michelle
    Hamilton, Pat
    Clausen, Saundra
    Young, Amy
    Sampath, Deepak
    Hong, Rebecca
    Lee, Man-Ling
    Blench, Toby
    Elliott, Richard
    Lu, Aijun
    Gu, Xiao-Hu
    Xin, Jianfeng
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [4] Isoform-Selective PI3K Inhibitors for Various Diseases
    Bheemanaboina, Rammohan R. Y.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (12) : 1074 - 1092
  • [5] Motility of human colorectal cancer cells is promoted by H1047R kinase mutation of PI3K p110-alpha
    Wan, Guanghua
    Ongchin, Melanie
    Hand, Essence
    Rajput, Ashwani
    [J]. CANCER RESEARCH, 2012, 72
  • [6] Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ
    Hassenrueck, Floyd
    Farina-Morillas, Maria
    Neumann, Lars
    Landini, Francesco
    Blakemore, Stuart James
    Rabipour, Mina
    Alvarez-Idaboy, Juan Raul
    Pallasch, Christian P.
    Hallek, Michael
    Rebollido-Rios, Rocio
    Krause, Guenter
    [J]. COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [7] Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ
    Floyd Hassenrück
    Maria Farina-Morillas
    Lars Neumann
    Francesco Landini
    Stuart James Blakemore
    Mina Rabipour
    Juan Raul Alvarez-Idaboy
    Christian P. Pallasch
    Michael Hallek
    Rocio Rebollido-Rios
    Günter Krause
    [J]. Communications Biology, 6
  • [8] PI3K isoform-selective inhibitors: next-generation targeted cancer therapies
    Wang, Xiang
    Ding, Jian
    Meng, Ling-hua
    [J]. ACTA PHARMACOLOGICA SINICA, 2015, 36 (10) : 1170 - 1176
  • [9] PI3K isoform-selective inhibitors: next-generation targeted cancer therapies
    Xiang Wang
    Jian Ding
    Ling-hua Meng
    [J]. Acta Pharmacologica Sinica, 2015, 36 : 1170 - 1176
  • [10] Improving the Armamentarium of PI3K Inhibitors with Isoform-Selective Agents: A new Light in the Darkness
    Rodon, Jordi
    Tabernero, Josep
    [J]. CANCER DISCOVERY, 2017, 7 (07) : 666 - 669
12345